Symbiomics Secures Strategic Investment from Corteva to Collaborate on Biologicals Innovation
Rafael de Souza, co-founder and CEO for Symbiomics (left) and Tom Greene, senior director at Corteva and global leader for Corteva Catalyst (right), on June 24, 2025, at the World Agri-Tech South American Summit in Sao Paulo, Brazil.
Symbiomics, a leading biotechnology company developing breakthrough microbiome solutions for more sustainable agriculture, today announced that it has successfully closed its Series A funding round with an equity investment led by Corteva, Inc. through its Corteva Catalyst platform.
Corteva, a global agriculture technology leader, will leverage its innovation pipeline to collaborate with Symbiomics to discover novel microbial solutions for better crop health and increased yields. The companies will explore applications of Symbiomics’ proprietary genomics discovery platform and its microbial strains with unique traits to bring together new solutions to farmers worldwide.
“The investment from Corteva represents an important recognition of Symbiomics as a company committed to developing innovative technologies for agribusiness,” said Rafael de Souza, co-founder and CEO for Symbiomics. “The Series A funding and Corteva collaboration will enable us to accelerate these developments and strengthen our position across the sector.”
Symbiomics is pioneering the discovery of microbials through genome sequencing and gene editing to develop next-generation biologicals solutions for agriculture. The company’s proprietary platform has identified thousands of microbes, with a significant number being sourced from different environments in Brazil and is actively developing products in plant nutrition, biostimulants and crop protection.
“We’re excited about the potential for Symbiomics’ biologicals solutions to be a smart and sustainable choice for farmers who are challenged by diseases and pest pressures that impact crop health and yield,” said Tom Greene, senior director at Corteva and global leader for Corteva Catalyst. “This investment further accelerates our goal of providing cutting edge innovation to farmers and reflects our strategic focus on the development of next-generation biological and naturally-inspired solutions.”
The round also includes investments from existing investors Arar Capital, Cazanga, MOV Investimentos, and The Yield Lab Latam, reinforcing continued confidence in Symbiomics’ platform. With the investment round secured, the company will continue to advance its discovery of novel microbes and development of technology based on genome editing and trait discovery. The funding will also help accelerate the company’s go-to-market timeline through strategic partnerships across the agribusiness sector.
Brazil is the second largest market in the world for Corteva and a key player in the global biologicals market. According to CropLife Brazil, the use of biological products is expanding rapidly in the country, with a 15% growth during the 2023-2024 harvest compared to the previous one, reaching BRL 5 billion in sales.
Get The Newsletter Today!
